The Role of Asymmetric Synthesis in Drug Discovery

Asymmetric synthesis is a foundational aspect of medicinal chemistry, offering essential insights into developing chiral molecules with high enantioselectivity. This chapter thoroughly introduces the basic principles of enantioselective synthesis, underscoring its critical importance in drug discovery and development. The ability to selectively produce single enantiomers is vital, given that the biological activity of many pharmaceutical agents is closely tied to their chirality and exploring the advantages of utilizing asymmetric synthesis, such as improved drug efficacy and reduced side effects, which are vital to advancing personalized medicine. The chapter also highlights the biological significance of chiral heterocycles, focusing on chiral amines and other compounds, and presents detailed examples of their synthetic schemes. By examining these aspects, the chapter illustrates how asymmetric synthesis facilitates the creation of more effective drugs and contributes to the ongoing innovation in medicinal chemistry. 

Terpenoids are vital components in the interactions and defence mechanisms among plants, microorganisms, and animals. These compounds hold considerable ecological significance, not only by protecting plants but also by influencing environmental factors that drive the evolution of plant communities and ecosystems. Their economic potential is also becoming increasingly recognized due to their wide application in human industries, including pharmaceuticals, food production, and chemical manufacturing. Additionally, terpenoids are emerging as biofuel candidates. Advances in synthetic biology, utilizing genomic resources and innovative tools, have improved the metabolic engineering of high-value terpenoids in both plants and microorganisms. Furthermore, their ecological importance has been underscored in developing sustainable pest control methods and enhancing plant resilience against environmental stresses. The continued exploration of the intricate metabolic and regulatory networks governing terpenoid biosynthesis is essential for realizing their full potential. This review provides an updated overview of the organization, regulation, and diversification of both core and specialized terpenoid metabolic pathways, while highlighting their prominent roles in therapeutic applications. In parallel, alkaloids, another significant class of natural compounds, are being synthesized using highly efficient methods. Recent approaches enable the enantioselective synthesis of complex alkaloids, such as yohimbine and tetrahydroprotoberberine, through innovative catalytic processes. These techniques facilitate access to a wide array of stereoisomeric forms, thus opening doors to novel biomedical research opportunities. The integration of flow chemistry and catalytic enantioselective reactions has streamlined the production of diverse alkaloid structures, enhancing the scope of both natural and synthetic analogues for therapeutic and pharmaceutical development.

Spirooxindoles are a class of organic compounds characterized by a spirocyclic framework, where an oxindole moiety (which is a structure containing an indole fused to a carbonyl group) is connected to another ring system via a spiro carbon atom. These compounds have attracted significant interest in medicinal chemistry due to their diverse biological activities. They have been studied for their potential as anticancer, anti-inflammatory, and antimicrobial agents. The structural diversity of spirooxindoles allows for a wide range of pharmacological activities, making them valuable scaffolds in drug design. This chapter compiles the recent synthetic schemes on asymmetric synthesis of spirooxindoles and their significance as potential drug candidates. It discusses the different synthetic routes used to prepare chiral spirooxindoles and highlights the impact of chirality on their biological activities.

The Biginelli reaction is considered one of the well-known examples of a multicomponent reaction that is useful in the synthesis of dihydropyrimidinones (DHPMs) using aryl aldehydes, urea, and esters and these are significant compounds in medicinal chemistry and chemical synthesis. DHPMs are considered vital compounds due to their diverse biological functions. Because of their remarkable and concentrated target-oriented biological activity, DHPMs have been the subject of large-scale and extensive research in the past few decades to determine how to synthesize them by using various catalysts and structural variations in a variety of solvents. Ionic liquids, Lewis acids, and organocatalysts are some of the chiral catalysts used in the enantioselective Biginelli reaction. This book chapter summarizes chiral reagents for asymmetric synthesis with particular absolute configuration. 

An emerging area of interest in medicinal chemistry has highlighted heterocyclic moieties as some of the most promising compounds in organic chemistry. Piperazine is a notable six-membered saturated N-heterocyclic moiety with a wide range of bioactive applications in the pharmaceutical industry. Molecules containing the piperazine core unit have demonstrated numerous beneficial activities, such as antibacterial, analgesic, antiviral, antihypertensive, anti-allergic, antimalarial, antipsychotic, antidepressant, cardioprotective, antifungal, antioxidant, antiinflammatory, and anticancer properties. The Food and Drug Administration (FDA) has approved various piperazine-based drugs for the treatment of several viral diseases, underscoring the pharmacological significance of piperazine analogues. In this chapter, we discuss in detail the procedures for the asymmetric synthesis of biologically active piperazine and its derivatives.

The utilization of naturally abundant resources is becoming more and more essential in the pursuit of green chemistry and sustainable development. Over the past two decades, the synthesis of organic compounds has increased interest in C-H functionalization. In organic chemistry, oxazine core unit molecules are renowned for their biological and synthetic significance along with numerous properties, such as ease of use, low cost, relative repeatability, stable products, and the absence of hazardous chemicals, high temperatures, pressures, or energies. The greener synthesis of oxazines is a step ahead of the preceding methodologies. In this book chapter, up-to-date improvements and novel trends in the green alternative synthesis of asymmetric oxazine have been highlighted and examined.

Chiral triazoles are of considerable importance in medicinal chemistry due to their dual antifungal and antibacterial activities. The chiral configuration of these molecules enables them to interact selectively with specific microbial targets, enhancing their efficacy. In antifungal applications, chiral triazoles inhibit the enzyme lanosterol 14α-demethylase, disrupting ergosterol biosynthesis, which is essential for maintaining fungal cell membrane integrity. This inhibition leads to membrane destabilization and ultimately fungal cell death. In antibacterial contexts, chiral triazoles can disrupt essential bacterial processes, such as cell wall synthesis or protein function, by binding to key bacterial enzymes or receptors. The ability of chiral triazoles to effectively target both fungi and bacteria makes them promising candidates for the creation of antibacterial drugs with a broad spectrum, particularly in the fight against drug-resistant strains.

Chiral benzimidazole derivatives have emerged as a significant class of compounds in pharmaceutical chemistry due to their wide range of potential biological and clinical applications. The present study explores the synthesis and biological potentialities of chiral benzimidazole derivatives, highlighting various synthetic approaches, including condensation, rearrangement, and green synthesis techniques. The chiral nature of these compounds, which is pivotal in their interaction with biological receptors, is discussed with a focus on methods for introducing and controlling chirality. Recent research findings highlight the remarkable biological activities of these derivatives, including carbonic anhydrase enzyme inhibition, antibacterial and antifungal properties, urease inhibition, ORL-1 antagonism, antitrypanosomal activity, antihypertensive effects, and inhibition of leukotriene biosynthesis. These activities position chiral benzimidazole derivatives as promising candidates for developing new therapeutic agents for a range of medical conditions. This study provides a comprehensive overview of the synthesis strategies and biological evaluations of chiral benzimidazole derivatives, underscoring their potential in pharmaceutical applications. 

The chapter gives an insight into the chemistry of chiral pharmaceuticals, discussing the different classes of compounds that have been synthesized using asymmetric methods. It covers the synthetic routes used to produce chiral pharmaceuticals and discusses the impact of chirality on their pharmacological properties. The chapter discusses key challenges in developing enantioselective syntheses for complex drug molecules, particularly those with intricate structures and multiple stereo-enters. It examines issues like controlling stereoselectivity, optimizing reaction conditions, and scaling up for industrial use. Additionally, the chapter explores the biological activities of chiral heterocycles, emphasizing how their stereochemistry impacts drug potency, selectivity, and metabolism. It highlights both the importance of enantioselective synthesis and the critical role of chiral heterocycles in the effectiveness of modern pharmaceuticals.